BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16177835)

  • 1. IgG and IgM isotypes of anti-cardiolipin and anti-beta2-glycoprotein i antibodies reflect different forms of recent thrombo-embolic events.
    Locht H; Wiik A
    Clin Rheumatol; 2006 Mar; 25(2):246-50. PubMed ID: 16177835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
    Lee SS; Cho ML; Joo YS; Kim WU; Hong YS; Min JK; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of antibodies against oxidised LDL in a cohort of 163 patients with positive anti-phospholipid antibodies and recent thrombosis.
    Locht H; Wiik A
    Rheumatol Int; 2006 Mar; 26(5):416-21. PubMed ID: 16189653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with ischemic stroke.
    Cojocaru IM; Cojocaru M; Muşuroi C; Botezat M
    Rom J Intern Med; 2003; 41(2):189-204. PubMed ID: 15526503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to anionic phospholipids and anti-beta2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus.
    Amoroso A; Mitterhofer AP; Del Porto F; Garzia P; Ferri GM; Galluzzo S; Vadacca M; Caccavo D; Afeltra A
    Hum Immunol; 2003 Feb; 64(2):265-73. PubMed ID: 12559629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
    Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T
    Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients.
    Gómez-Pacheco L; Villa AR; Drenkard C; Cabiedes J; Cabral AR; Alarcón-Segovia D
    Am J Med; 1999 Apr; 106(4):417-23. PubMed ID: 10225244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome].
    Reshetniak TM; Derksen RV; Alekberova ZS; Horbach D; De Groot F; Nasonov EL; Kalashnikova LA; Match ES; Nasonova VA
    Klin Med (Mosk); 1998; 76(3):36-40. PubMed ID: 9575746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.
    Villalta D; Alessio MG; Tampoia M; Da Re A; Stella S; Da Re M; Tozzoli R; Bizzaro N
    Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
    Nojima J; Kuratsune H; Suehisa E; Iwatani Y; Kanakura Y
    Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the anti-beta2-glycoprotein I antibody provide additional information in patients with thrombosis?
    Lee EY; Lee CK; Lee TH; Chung SM; Kim SH; Cho YS; Yoo B; Moon HB
    Thromb Res; 2003; 111(1-2):29-32. PubMed ID: 14644075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M; Duzgun N; Tunc SE; Tutkak H
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lupus anticoagulant, high levels of anticardiolipin, and anti-beta2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension.
    Martinuzzo ME; Pombo G; Forastiero RR; Cerrato GS; Colorio CC; Carreras LO
    J Rheumatol; 1998 Jul; 25(7):1313-9. PubMed ID: 9676762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.